Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;33(5):966-74.
doi: 10.1097/HJH.0000000000000500.

Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis

Affiliations

Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis

Otto A Sanchez et al. J Hypertens. 2015 May.

Abstract

Background: Longitudinal associations between the aminoterminal pro-B-type natriuretic peptide (NT-proBNP) and incident hypertension are lacking.

Methods: We tested associations between baseline NT-proBNP (bNT-proBNP) and change in NT-proBNP (ΔNT-proBNP) (visit 3 NT-proBNP - bNT-proBNP, 3.2 years apart) with incident hypertension (SBP ≥ 140 and/or DBP ≥90 mmHg or taking antihypertensive medications). Incident hypertension was evaluated in 5596 individuals in the Multi-Ethnic Study of Atherosclerosis without hypertension at baseline (53% women, age range 45-84 years without overt cardiovascular disease) and follow-up for 9.5 years and in a subgroup (1550) who had bNT-proBNP less than 100 pg/ml and no hypertension at visit 3. Incident hypertension was regressed (proportional hazards) on quintiles of bNT-proBNP (range) (reference <19.2, 19.3-40.8, 40.9-70.9, 71-135.2, and >135.5) and also on ΔNT-proBNP categories (reference <-10, -10 to 10, >10 to 50, and >50 pg/ml). Hazard ratios were adjusted for age, race, sex, education, diabetes, obesity, left ventricle mass/height, SBP and DBP, interleukin-6, salt intake, estimated glomerular filtration rate, and exercise.

Results: Compared with the reference category, hazard ratios (95% confidence interval) for incident hypertension compared with the first quintile of bNT-proBNP were 1.47 (1.13-1.93), 1.57 (1.18-2.09), 1.52 (1.12-2.06), and 2.36 (1.62-3.41). Hazard ratios for incident hypertension by categories of ΔNT-proBNP from 3.2 to 9.5 years follow-up were 0.98 (0.62-1.56), 1.13 (0.72-1.79), and 1.82 (1.07-3.12).

Conclusion: The development of hypertension tended to be preceded by elevated levels of bNT-proBNP or a substantial positive ΔNT-proBNP.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cross-sectional analysis at baseline. Dip in NT-proBNP levels observed in pre-hypertensive BP categories. Values are back transformed geometric means ± 95% CI. Model 1 adjusted for age, race and gender. Model 2 = model 1 + highest level of education, presence of diabetes, presence of obesity (BMI > 30 kg/m2), left ventricular end diastolic volume, heart rate categories < or > then 60 beats per minute, left ventricular mass/height, add table salt, estimated glomerular filtration rate, IL-6, and total intentional exercise in MET-min/week. * indicates that NT-proBNP is lower in category c than in categories a, b, d and e for both model 1 and 2, p < 0.02.
Figure 2
Figure 2
NT-proBNP values as a function of left ventricular diastolic wall distensibility. NT-proBNP values are back transformed geometric means ± 95% CI. Quadratic model adjusted for age, race and sex, p < 0.0001.
Figure 3
Figure 3
Hazard ratios for incident hypertension according to quintiles of NT-proBNP concentrations. Prospective analysis using baseline NT-proBNP and any incident high blood pressure at exams 2–5 (9.7 yr followup), N=2925. Hazard ratios ± 95% CI. Models 1 and 2 covariates are described in Methods and in the footnote to Table 2. Bar represents the hazard ratio reference line. p values for trend for linear associations regressed on NT-proBNP as a continuous variable for model 1 < 0.0001 and model 2 = 0.0007. Quadratic associations were not significant.

Comment in

Similar articles

Cited by

References

    1. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. Journal of Human Hypertension. 1993;7 (3):245–250. - PubMed
    1. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992;92 (1):29–34. - PubMed
    1. Macheret F, Heublein D, Costello-Boerrigter LC, Boerrigter G, McKie P, Bellavia D, et al. Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP. Journal of the American College of Cardiology. 2012;60 (16):1558–1565. - PMC - PubMed
    1. Freitag MH, Larson MG, Levy D, Benjamin EJ, Wang TJ, Leip EP, et al. Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension. 2003;41 (4):978–983. - PubMed
    1. Fox ER, Musani SK, Singh P, Bidulescu A, Nagarajarao HS, Samdarshi TE, et al. Association of plasma B-type natriuretic peptide concentrations with longitudinal blood pressure tracking in African Americans: findings from the Jackson Heart Study. Hypertension. 2013;61 (1):48–54. - PMC - PubMed

Publication types